Get the Stockscreener App
79.91
4.50%
-3.812
Hologic Inc stock is traded at $79.91, with a volume of 1.78M.
It is down -4.50% in the last 24 hours and down -0.36% over the past month.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$83.72
Open:
$79.98
24h Volume:
1.78M
Relative Volume:
1.27
Market Cap:
$18.50B
Revenue:
$3.99B
Net Income/Loss:
$701.50M
P/E Ratio:
41.40
EPS:
1.93
Net Cash Flow:
$1.01B
1W Performance:
-1.09%
1M Performance:
-0.36%
6M Performance:
+4.46%
1Y Performance:
+16.43%
1-Day Range:
$77.50
$81.14
1-Week Range:
$77.50
$84.39
52-Week Range:
$66.93
$84.67
Hologic Inc Stock (HOLX) Company Profile
Name
Hologic Inc
Sector
Industry
Phone
(508) 263-2900
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-27-24 | Initiated | Stephens | Overweight |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-23 | Upgrade | Needham | Hold → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-20-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| Jul-18-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Oct-14-21 | Initiated | Redburn | Neutral |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-20-20 | Downgrade | Needham | Buy → Hold |
| Nov-05-20 | Reiterated | Needham | Buy |
| Jun-30-20 | Upgrade | Cowen | Market Perform → Outperform |
| Jun-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-30-20 | Reiterated | Needham | Buy |
| Apr-30-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-07-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-27-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Jan-31-19 | Reiterated | Needham | Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-09-18 | Initiated | UBS | Neutral |
| Sep-13-18 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Hologic Inc Stock (HOLX) Latest News
Needham maintains Buy on Hologic shares following F4Q24 revenue beat By Investing.com - Investing.com UK
Hologic Q4 Earnings Lag, Revenues Top, Stock Down In Aftermarket - Barchart
Hologic (NASDAQ:HOLX) Announces Earnings Results, Meets Estimates - MarketBeat
Hologic Q4 Earnings Lag, Revenues Top, Stock Down in Aftermarket - Yahoo Finance
Earnings call: Hologic reports solid Q4 and FY 2024 results, optimistic for 2025 - Investing.com Australia
Hologic Inc (HOLX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Challenges - GuruFocus.com
Hologic Reports Robust Q4 2024 Financial Growth - TipRanks
Hologic Faces Revenue Challenges After Halting Machine Shipments - Finimize
Hologic: Fiscal Q4 Earnings Snapshot - The Washington Post
Hologic (NASDAQ:HOLX) Updates Q1 2025 Earnings Guidance - MarketBeat
Hologic (HOLX) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Hologic (HOLX) Q4 Earnings Miss Estimates - Yahoo Finance
Hologic Inc (HOLX) Q4 2024 Earnings: EPS of $0.76 Beats Estimates, Revenue Hits $987.9 Million - GuruFocus.com
Hologic shares slip on soft guidance despite in-line Q4 results - Investing.com
Hologic earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
Hologic, Inc. Reports Earnings Results for the Fourth Quarter Ended September 29, 2024 - Marketscreener.com
When Should You Buy Hologic, Inc. (NASDAQ:HOLX)? - Simply Wall St
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Pallas Capital Advisors LLC - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Stephens Investment Management Group LLC Purchases 15,134 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic Inc. stock outperforms competitors despite losses on the day - MarketWatch
Will Non-COVID-19 Diagnostics Sales Drive Hologic's Q4 Earnings? - MSN
Hologic, Inc. (NASDAQ:HOLX) Shares Purchased by Congress Asset Management Co. - MarketBeat
Top 10 Medical Imaging Companies | Provides Best DiagnosticsMarket.us Media - Market.us Media - United States Market News
Hologic's Quarterly Earnings Preview: What You Need to Know - MSN
Hologic Inc. stock outperforms competitors on strong trading day - MarketWatch
Unlocking Q4 Potential of Hologic (HOLX): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight - GlobeNewswire Inc.
Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know - MSN
Hologic: Continued Room Amidst Bolt-On M&A Efforts (NASDAQ:HOLX) - Seeking Alpha
Hologic's Quarterly Earnings Preview: What You Need To Know - Barchart
FDA advises clinicians to stop using Hologic radiographic markers - MedTech Dive
Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Breast Biopsy Vacuum System Market 2024: Analysis by Current - openPR
Hologic (HOLX) to Release Earnings on Monday - MarketBeat
State of Alaska Department of Revenue Has $15.41 Million Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Assenagon Asset Management S.A. Sells 254,462 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
BioZorb Recall Issued for All Breast Tissue Markers Following Implant Migration, Erosion Problems - AboutLawsuits.com
Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints - Benzinga
FDA says ‘do not use’ Hologic BioZorb Markers - TipRanks
Raymond James & Associates Has $25.33 Million Stock Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic's SWOT analysis: women's health leader faces growth challenges - Investing.com India
Hologic Faces Lawsuit Over BioZorb Complications Experienced by Five Breast Cancer Patients - AboutLawsuits.com
Allspring Global Investments Holdings LLC Raises Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Hologic to lay off 86 people in closure of Connecticut facility - MedTech Dive
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know - Yahoo Finance
Hologic Inc Stock (HOLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
2.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):